Moderna’s Dr. Stephen Hoge on AI and the future of healthcare

Blackstone .

Blackstone

Messenger RNA is nature’s software, the instructions that tell every cell in your body what to do. Moderna has spent more than a decade learning to write it.

On Inside Blackstone, Moderna (NASDAQ: MRNA) President Dr. Stephen Hoge sits down with host Christine Anderson to talk about the future of medicine. He explains how mRNA works, where AI in healthcare is accelerating drug discovery, and the science behind why no two cancers are the same. He walks through the engineering behind an individualized cancer treatment made for one patient at a time, and offers his view on what investors may be underestimating about AI in life sciences. Plus, he shares the fasting habit he’s kept for almost 10 years.

The headlines tell you what happened. Inside Blackstone helps you see what may be coming next.

Time stamps (full transcript available here)

  • 00:00 — Welcome to Inside Blackstone
  • 01:04 — The Monday Morning Meeting
  • 03:58 — Economic Weather Report
  • 06:27— Dr. Stephen Hoge Comes Inside Blackstone
  • 07:11 — What is mRNA?
  • 09:03 — How Moderna Designed Its COVID Vaccine in an Hour
  • 11:21 — The Case for Optimism on AI in Healthcare
  • 15:24 — Inside Moderna’s Melanoma Cancer Vaccine Trial
  • 16:30 — Every Cancer is Unique
  • 17:56 — Creating Individualized Medications at Scale
  • 18:41 — A Medicine for One Patient in Six Weeks
  • 22:11 — What Investors May Be Underestimating
  • 23:34 — Blackstone Life Sciences and the Moderna Flu Vaccine
  • 26:33 — What’s Next: Rare Genetic Disease
  • 28:11 — STEM + Humanities
  • 28:57 — Fasting Two Days a Week
  • 30:12 — The Debrief

Key takeaways

  • mRNA works like software. Once Moderna cracked the code for one medicine, it could copy and paste to treat multiple diseases.
  • AI is speeding up discovery, but medicine is still physical. A treatment still has to be made, tested in people, and given time to show results.
  • Personalized medicine requires a new kind of manufacturing. Stephen Hoge explains Moderna’s approach to creating individualized treatments.

Never miss an episode of Inside Blackstone

New episodes will be published every Tuesday. Hit the follow button above, or subscribe on YouTube, Spotify, and Apple Podcasts.

The information in this material is general information only and is intended solely for licensed financial advisers or authorised representatives of licensed financial advisers and wholesale client investors. It is not intended to constitute financial product advice or an offer, invitation, solicitation or recommendation to invest. This information must not be distributed, delivered, disclosed or otherwise disseminated to any investor. It has been prepared without taking into account any person’s investment objectives, financial situation or needs. Investors should consider whether the information is suitable to their circumstances.



1 stock mentioned

Blackstone .
Blackstone

Blackstone is the world’s largest alternative asset manager. Blackstone seeks to deliver compelling returns for institutional and individual investors by strengthening the companies in which the firm invests. Blackstone’s US$1.3 trillion in assets...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment